Actio Biosciences’ Series B round will be used to support research initially focused on rare diseases, but it sees having broad potential, too.Dive Brief:Actio Biosciences, a San Diego-based biotechnology startup, announced Wednesday it raised a $66 million Series B financing to support drug research it’s initially aiming at rare genetic diseases, but sees having broader […]
